Holen Sie sich die Stockscreener-App
9.52
3.70%
0.34
Handel nachbörslich:
9.34
-0.18
-1.89%
Schlusskurs vom Vortag:
$9.18
Offen:
$9.21
24-Stunden-Volumen:
1.13M
Relative Volume:
2.45
Marktkapitalisierung:
$775.37M
Einnahmen:
$81.39M
Nettoeinkommen (Verlust:
$-114.20M
KGV:
-6.6793
EPS:
-1.4253
Netto-Cashflow:
$-50.60M
1W Leistung:
+17.68%
1M Leistung:
+36.00%
6M Leistung:
+13.20%
1J Leistung:
+67.61%
1-Tages-Spanne:
$9.1503
$9.88
1-Wochen-Bereich:
$8.28
$9.88
52-Wochen-Spanne:
$4.55
$9.88
Meiragtx Holdings Plc Stock (MGTX) Company Profile
Firmenname
Meiragtx Holdings Plc
Sektor
Branche
Telefon
646-860-7985
Adresse
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
9.52 | 747.68M | 81.39M | -114.20M | -50.60M | -1.4253 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-10-21 | Eingeleitet | Raymond James | Strong Buy |
| 2024-07-31 | Fortgesetzt | Chardan Capital Markets | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-09-15 | Fortgesetzt | BofA Securities | Buy |
| 2019-09-03 | Eingeleitet | Piper Jaffray | Overweight |
| 2019-02-27 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-07-03 | Eingeleitet | Barclays | Overweight |
| 2018-07-03 | Eingeleitet | BofA/Merrill | Buy |
Alle ansehen
Meiragtx Holdings Plc Aktie (MGTX) Neueste Nachrichten
MeiraGTx (NASDAQ:MGTX) Hits New 52-Week HighTime to Buy? - marketbeat.com
MeiraGTx (NASDAQ:MGTX) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
(MGTX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
MGTX Technical Analysis & Stock Price Forecast - Intellectia AI
What Does The Future Hold For MeiraGTx Holdings plc (NASDAQ:MGTX)? These Analysts Have Been Cutting Their Estimates - Sahm
MeiraGTx Holdings plc Ordinary Shares MGTX ) Stock Price Today & Analysis - Gotrade
MeiraGTx Holdings plc Ordinary Shares (MGTX) Stock Price Today & Analysis - heygotrade.com
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs | MGTX Stock News - GuruFocus
MeiraGTx Holdings PLC $MGTX Shares Bought by Hennion & Walsh Asset Management Inc. - marketbeat.com
MGTX: Evercore ISI Group Lowers Price Target for MeiraGTx Hldgs - GuruFocus
Strength Displayed by MeiraGTx (MGTX): Will Its 6.2% Surge Lead to Further Gains? - Bitget
Strength Seen in MeiraGTx (MGTX): Can Its 6.2% Jump Turn into More Strength? - Yahoo Finance
Performance Recap: Can MeiraGTx Holdings plc deliver consistent EPS growth2026 Rallies & Community Trade Idea Sharing Platform - baoquankhu1.vn
MeiraGTx Holdings plc (NASDAQ:MGTX) Analysts Are Cutting Their Estimates: Here's What You Need To Know - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
MeiraGTx 2025 Annual Report Highlights: Gene Therapy Pipeline, Strategic Partnerships, and Proprietary Riboswitch Platform - Minichart
MeiraGTx 2025 10-K: Revenue $81.4M, EPS (1.42) - TradingView
MeiraGTx (NASDAQ: MGTX) expands gene therapy partnerships and manufacturing - Stock Titan
MeiraGTx Holdings plc (MGTX) Stock Price Prediction: Today, Tomorrow, Next Week - Traders Union
Live MeiraGTx Holdings plc (MGTX) Technical Analysis - tradersunion.com
Chardan Capital Reiterates “Buy” Rating for MeiraGTx (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (MGTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
MGTX SEC FilingsMeiragtx Holdings Plc 10-K, 10-Q, 8-K Forms - Stock Titan
MeiraGTx Holdings PLC (MGTX) Q4 earnings and revenues surpass estimates - MSN
Piper Sandler cuts MeiraGTx stock price target on valuation By Investing.com - Investing.com Australia
Piper Sandler Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $26.00 - MarketBeat
Piper Sandler cuts MeiraGTx stock price target on valuation - Investing.com UK
MeiraGTx (NASDAQ:MGTX) Issues Earnings Results - marketbeat.com
MeiraGTx (NASDAQ:MGTX) Price Target Raised to $16.00 at Bank of America - MarketBeat
MeiraGTx (NASDAQ:MGTX) Earns Buy Rating from Chardan Capital - MarketBeat
MeiraGTx Receives FDA Breakthrough Therapy Designation for AAV2-hAQP1 and Reports Strong 2025 Financial Results - Minichart
BofA raises MeiraGTx stock price target to $16 on FDA designation - uk.investing.com
BofA raises MeiraGTx stock price target to $16 on FDA designation By Investing.com - Investing.com India
MeiraGTx Highlights Breakthrough Gene Therapy and Strategic Alliances - TipRanks
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading VolumeShould You Buy? - MarketBeat
MeiraGTx shares see Raymond James price target cut on launch timing By Investing.com - Investing.com South Africa
MeiraGTx shares see Raymond James price target cut on launch timing - Investing.com UK
MeiraGTx Holdings PLC (MGTX) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
MGTX Receives Breakthrough Designation for Xerostomia Treatment - GuruFocus
MeiraGTx Extends Perceptive Notes to May 2027, Plans $25M Redemption; Warrants Repriced to $8 - TradingView
MeiraGTx (Nasdaq: MGTX) gains FDA breakthrough tag and extends debt maturity - Stock Titan
MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results - The Manila Times
FDA grants breakthrough status to MeiraGTx dry-mouth gene therapy - Stock Titan
MeiraGTx Highlights Late-Stage Gene Therapy Pipeline at RBC Ophthalmology Conference - MarketBeat
MeiraGTx (NASDAQ:MGTX) CEO Sells $459,420.00 in Stock - MarketBeat
MeiraGTx Holdings plc (MGTX) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Meiragtx Holdings Insider Sold Shares Worth $459,420, According to a Recent SEC Filing - marketscreener.com
Insider Sell Alert: Alexandria Forbes Sells 62,000 Shares of Mei - GuruFocus
Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock By Investing.com - Investing.com South Africa
Forbes Alexandria, president & CEO of MeiraGTx, sells $459k in MGTX stock - Investing.com
MeiraGTx (MGTX) CEO sells 62K shares at $7.41 under 10b5-1 plan - Stock Titan
Finanzdaten der Meiragtx Holdings Plc-Aktie (MGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):